Poster - 28 July 2024 Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials
Poster - 19 May 2024 Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists
Article - 17 May 2024 Leveraging global laboratory scale to deliver critical patient test results on time
Poster - 20 October 2024 Receptor occupancy assay development challenges for rare targets of bispecific drugs Read Moreabout Receptor occupancy assay development challenges for rare targets of bispecific drugs
Poster - 20 October 2024 Per- and polyfluoroalkyl substances (PFAS): Validation of methodology for the determination of residues in fruit, fruit processed commodities and fish tissues Read Moreabout Per- and polyfluoroalkyl substances (PFAS): Validation of methodology for the determination of residues in fruit, fruit processed commodities and fish tissues
Poster - 20 October 2024 Validation of a quantitative PCR (qPCR) assay for the detection and quantification of replication competent lentivirus for patient monitoring in lentiviral vector-based cell therapy studies Read Moreabout Validation of a quantitative PCR (qPCR) assay for the detection and quantification of replication competent lentivirus for patient monitoring in lentiviral vector-based cell therapy studies
Info Sheet - 1 August 2024 Nonclinical Solutions - Toxicology Read Moreabout Nonclinical Solutions - Toxicology
Poster - 28 July 2024 Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials Read Moreabout Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials
Video - 25 April 2024 From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)
Info Sheet - 23 July 2024 Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability Read Moreabout Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability
Info Sheet - 23 July 2024 Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services Read Moreabout Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services
Article - 14 May 2024 Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese) Read Moreabout Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)
Info Sheet - 2 May 2024 Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities Read Moreabout Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities
Article - 8 April 2024 Navigating complexities in ADC development with specialized global laboratory support and scientific expertise Read Moreabout Navigating complexities in ADC development with specialized global laboratory support and scientific expertise
Article - 8 April 2024 Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials Read Moreabout Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials
Article - 7 December 2023 OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial Read Moreabout OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial
Article - 6 December 2023 Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay Read Moreabout Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Article - 28 September 2023 Cell therapy for treatment of cancer Read Moreabout Cell therapy for treatment of cancer